Showing results (91-100 of 125) with videos related to

Sort By:
Pageof 13
Ebiomedicine|January 18, 2019
Targeting SET to restore PP2A activity disrupts an oncogenic CIP2A-feedforward loop and impairs triple negative breast cancer progressionChun-Yu Liu, Tzu-Ting Huang, Yi-Ting Chen, et al.
Metabolism: Clinical and Experimental|September 17, 2023
Hepatocyte TIPE2 is a fasting-induced Raf-1 inactivator that drives hepatic gluconeogenesis to maintain glucose homeostasisYan Tao, Jingyuan Zhao, Jilong Yin, et al.
The Journal of Clinical Investigation|March 16, 2021
Bile acid-activated macrophages promote biliary epithelial cell proliferation through integrin αvβ6 upregulation following liver injuryAdrien Guillot, Lucia Guerri, Dechun Feng, et al.
Medicine|August 8, 2015
Impact of Comorbidity and Age on Determinants Therapeutic Strategies in Advanced Pancreatic Head Cancer Patients With Obstructive JaundicesYu-Guang Chen, Hsueh-Hsing Pan, Ming-Shen Dai, et al.
Journal of the Chinese Medical Association : JCMA|November 11, 2024
Real-world outcomes of everolimus-based treatment in a Taiwanese cohort with metastatic HR+/HER2- breast cancerYun-Chieh Kao, Yi-Fang Tsai, Shih-Che Shen, et al.
Circulation|June 10, 2026
Endothelial SHMT2 Drives Pulmonary Vascular Remodeling Through Noncanonical Pathway in Pulmonary HypertensionQianqian Wang, Jingjing Tian, Dongdong Liu, et al.
Nature Communications|August 14, 2025
Obesity-associated macrophages dictate adipose stem cell ferroptosis and visceral fat dysfunction by propagating mitochondrial fragmentationYan Tao, Jinhao Zang, Tianci Wang, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 26, 2022
Population pharmacokinetics for oral paclitaxel in patients with advanced/metastatic solid tumorsJimmy He, Christopher G C A Jackson, Sanjeev Deva, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 19, 2019
Caspase-1 Activation Is Related With HIV-Associated Atherosclerosis in an HIV Transgenic Mouse Model and HIV Patient CohortAlison C Kearns, Fengming Liu, Shen Dai, et al.
Breast Cancer Research and Treatment|June 21, 2023
Plasma cell-free tumor DNA, PIK3CA and TP53 mutations predicted inferior endocrine-based treatment outcome in endocrine receptor-positive metastatic breast cancerTom Wei-Wu Chen, Wen Hsiao, Ming-Shen Dai, et al.
Pageof 13